GGrantIndex
← Leaderboards

Roberta Anderson Ballard

Children'S Hospital Of Philadelphia

$14,822,665
Attributed
$14,822,665
Total exposure
11
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY200513
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$14,822,665 · 11

By mechanism

U01$14,087,200 · 2
M01$452,332 · 8
P50$283,133 · 1

Top collaborators

No co-investigators on record.

Most similar at Children'S Hospital Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationNitric OxideClinical ResearchHuman SubjectBronchopulmonary DysplasiaPremature Infant HumanClinical TrialsBiomarkerOxidative StressRespiratory Disorder ChemotherapyRespiratory TherapyHuman Therapy EvaluationPulmonary SurfactantsChemopreventionRespiratorsLung InjuryCytokineDrug Screening /EvaluationTissue Resource /RegistryBiochemicalBaseAlveolarAsthmaCaffeine

Grant awards (22)

Trial of Late SURFactant (TOLSURF) to Prevent BPD - Clinical Coord Ctr$952,443
U01 · FY2013 · HL · contact PI
Trial of Late SURFactant (TOLSURF) to Prevent BPD - Clinical Coord Ctr$1,383,645
U01 · FY2012 · HL · contact PI
Trial of Late SURFactant (TOLSURF) to Prevent BPD - Clinical Coord Ctr$1,626,614
U01 · FY2011 · HL · contact PI
Trial of Late SURFactant (TOLSURF) to Prevent BPD - Clinical Coord Ctr$1,604,244
U01 · FY2010 · HL · contact PI
Trial of Late SURFactant (TOLSURF) to Prevent BPD - Clinical Coord Ctr$1,787,395
U01 · FY2009 · HL · contact PI
CORE--CLINICAL$283,133
P50 · FY2005 · HL
PATHOBIOLOGY OF BRONCHOPULMONARY DYSPLASIA$35,672
M01 · FY2005 · RR
LOW DOSE INO IN CHRONIC LUNG DISEASE IN PRETERM INFANT$32,318
M01 · FY2005 · RR
LOW DOSE INO IN CHRONIC LUNG DISEASE IN PRETERM INFANT$23,996
M01 · FY2005 · RR
PATHOBIOLOGY OF BRONCHOPULMONARY DYSPLASIA$1,097
M01 · FY2005 · RR
Low dose INO in chronic lung disease in preterm infant$105,123
M01 · FY2004 · RR
Pathobiology of bronchopulmonary dysplasia$30,959
M01 · FY2004 · RR
Low dose INO in chronic lung disease in preterm infant$21,869
M01 · FY2004 · RR
Pathobiology of bronchopulmonary dysplasia$14,053
M01 · FY2004 · RR
INHALED NO IN PREVENTION OF CHRONIC LUNG DISEASE$1,604,333
U01 · FY2003 · HL
INHALED NO IN PREVENTION OF CHRONIC LUNG DISEASE$1,839,151
U01 · FY2002 · HL
PATHOBIOLOGY OF BRONCHOPULMONARY DYSPLASIA$186,685
M01 · FY2002 · RR
NITRIC OXIDE FOR CHRONIC LUNG DISEASE IN PRETERM INFANT$0
M01 · FY2002 · RR
INHALED NO IN PREVENTION OF CHRONIC LUNG DISEASE$1,741,773
U01 · FY2001 · HL
INHALED NO IN PREVENTION OF CHRONIC LUNG DISEASE$1,547,602
U01 · FY2000 · HL
PATHOBIOLOGY OF BRONCHOPULMONARY DYSPLASIA$560
M01 · FY2000 · RR
NITRIC OXIDE FOR CHRONIC LUNG DISEASE IN PRETERM INFANT$0
M01 · FY2000 · RR